ABIVAX to market typhoid, meningococcus vaccines in Asia

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2014

Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, has collaborated with Finlay Institute, Hava...Read more

Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2016

Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the next decade, rising from approximately $640 million in 2014 to over $2....Read more

Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 May, 2016

Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With th...Read more

Merck gets FDA nod for Bridion

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Dec, 2015

Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium) for the reversa...Read more

BioDiem gets hepatitis vaccine tech from Canberra univ

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

Infect mosquitoes with Wolbachia, stop diseases

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

Takeda close to releasing Norovirus vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

China to set up a new vaccine tracking system

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2016

Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to trade vaccines in the country. The decision comes as a huge scandal ...Read more

Yisheng BioPharma gets positive result in rabies vaccine trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I clinical trial of PIKA rabies vaccine, an investigational vaccine des...Read more

China's Hualan Bio gets WHO nod for influenza vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan. Flu is one of the most s...Read more

Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

German firm proceeds on ebola vaccine trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2015

Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the clinical trial of its investigational vaccine against Ebola virus diseas...Read more

Merck's Ebola vaccine found promising in clinical trials

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2015

Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "highly effective," in clinical trials. The vaccine was tested on more th...Read more

Teva recalls Adrucil injection for potential foriegn particle presence

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Jul, 2015

Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential presence of particulate matter identified as aggregate of silicone rubber...Read more

Drug resistance keeps malaria threat alive in India

Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 02 Jul, 2012

The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011. According to statistics...Read more

New vaccine against Hepatatis B developed by Cuba

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNasvac, developed in cooperation French company Abivax, is currently und...Read more

Malaria vaccine, Mosquirix, gets European nod

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...Read more

Novavax's Ebola vaccine shows promise in human trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early stage human clinical trial. The vaccine induced a substantial immune...Read more